CHARLES SCHWAB INVESTMENT MANAGEMENT INC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$78,349,000
+115.5%
921,422
-10.2%
0.04%
+100.0%
Q2 2020$36,353,000
+118.6%
1,025,751
-16.8%
0.02%
+80.0%
Q1 2020$16,630,000
-33.1%
1,233,614
+5.0%
0.01%
-23.1%
Q4 2019$24,863,000
+70.6%
1,174,991
+6.9%
0.01%
+44.4%
Q3 2019$14,573,000
-1.9%
1,099,000
+2.6%
0.01%0.0%
Q2 2019$14,860,000
-22.0%
1,071,369
+8.1%
0.01%
-25.0%
Q1 2019$19,042,000
+49.5%
991,227
+11.0%
0.01%
+20.0%
Q4 2018$12,738,000
-28.3%
892,622
+4.7%
0.01%
-16.7%
Q3 2018$17,761,000
-4.4%
852,625
+8.6%
0.01%
-14.3%
Q2 2018$18,584,000
+132.0%
785,099
+43.2%
0.01%
+133.3%
Q1 2018$8,012,000
-4.2%
548,325
+6.0%
0.01%
-14.3%
Q4 2017$8,359,000
+27.7%
517,259
+10.4%
0.01%
+16.7%
Q3 2017$6,548,000
+295.6%
468,380
+150.0%
0.01%
+200.0%
Q2 2017$1,655,000
+58.8%
187,348
+16.4%
0.00%
+100.0%
Q1 2017$1,042,000
+19.9%
160,948
-32.0%
0.00%0.0%
Q4 2016$869,000
+35.6%
236,548
+20.0%
0.00%0.0%
Q3 2016$641,000
+40.0%
197,0480.0%0.00%0.0%
Q2 2016$458,000
-7.1%
197,0480.0%0.00%0.0%
Q1 2016$493,000
-18.5%
197,0480.0%0.00%0.0%
Q4 2015$605,000
+46.8%
197,048
-17.7%
0.00%0.0%
Q3 2015$412,000
-48.4%
239,448
+21.7%
0.00%0.0%
Q2 2015$799,000
+6.0%
196,7480.0%0.00%0.0%
Q1 2015$754,000
-20.2%
196,7480.0%0.00%0.0%
Q4 2014$945,000
+29.1%
196,7480.0%0.00%0.0%
Q3 2014$732,000
+1.8%
196,7480.0%0.00%0.0%
Q2 2014$719,000
+31.9%
196,748
+52.2%
0.00%0.0%
Q1 2014$545,000
-8.4%
129,3000.0%0.00%0.0%
Q4 2013$595,000
-32.5%
129,3000.0%0.00%
-50.0%
Q3 2013$881,000
-31.0%
129,300
-44.3%
0.00%
-33.3%
Q2 2013$1,276,000232,3000.00%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders